MICRO-X LIMITED — Regulatory Filings 2021

Jun 21, 2021

Micro-X Limited, ABN 21 153 273 735

==> picture [159 x 46] intentionally omitted <==

MICRO-X ROVER ENTERS EMEA MARKET – EXHIBITING AT ARAB HEALTH 2021

Arab Health 2021 Conference 21-24 June 2021 - Micro-X Rover showcased by new distributor Roesys MedTec GmbH

Adelaide, Australia, 22[nd] June 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for health and security markets globally, announces the first public showing of the Micro-X Rover mobile X-ray unit at the Arab Health 2021 Conference in connection with its entry into the Europe, Africa and Middle East ( EMEA ) market.

Highlights:

• EMEA is a large and fast growing healthcare market where the Micro-X Rover is ideally suited

• Micro-X Rover is being exhibited at Arab Health 2021 Conference – 50,000 healthcare delegates expected

• Non-exclusive distributor agreement with Roesys MedTec GmbH – specialist in EMEA market

• Creating additional paths to markets for Micro-X branded product

About Arab Health 2021

Arab Health 2021 is a leading medical equipment exhibition in the Middle East showcasing the latest innovations in healthcare and is established as a ‘must attend’ event for the EMEA region. Held at the Dubai World Trade Centre, it is the first of the major annual radiology/healthcare exhibitions to be held ‘live and in-person’ in the last 18 months and is expected to host more than 50,000 international healthcare and trade professionals.

The Micro-X Rover unit will be on display at a booth at Arab Health 2021 which will be hosted by Micro-X distributor, Roesys, a specialist distributor in radiology equipment for the EMEA region. Micro-X technical sales staff will also be in attendance to demonstrate the Rover’s state-of-the-art imaging, lightweight design, ease of use and manoeuverability to the healthcare community.

Growing Mobile DR Sales in the EMEA market through New Distributor Agreement

In line with Micro-X’s plan to develop multiple paths to market and after receiving approval of its 510(k) application from the FDA for its Rover bedside imager now with Varex detector and software, Micro-X has now signed a non-exclusive 3 year term distributor agreement with Roesys to distribute the Micro-X Rover.

Roesys, based in Espelkamp, Germany, sells X-ray technology and modern radiography systems throughout the EMEA region. Roesys will promote, market, distribute and sell the Micro-X branded Rover into hospitals through their extensive sub-distributor operations across the EMEA region building the Micro-X brand and increasing global awareness of the Rover product.

Micro-X’s Managing Director, Peter Rowland, commented:

“We are excited to see Rover exhibited at Arab Health 2021 now as a Micro-X product and engage with the EMEA healthcare community as we see interest building in our innovative technology. This agreement with Roesys will allow us to access the very large EMEA market and extend the sales opportunity of our own branded, X-ray imaging system.”

This ASX Announcement is authorised by the Board of Micro-X.

– ENDS –

Micro-X Limited, ABN 21 153 273 735, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA

www.micro-x.com

==> picture [127 x 37] intentionally omitted <==

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has two mobile digital medical x-ray systems being sold commercially for diagnostic healthcare applications and Micro-X medical products are now in operation in 14 countries around the world.

Micro-X has a portfolio of innovative products in development, including the MBI for imaging Improvised Explosive Devices in security, defence and counter-terrorism applications; a next-generation self-service X-Ray Airport Checkpoint Portal with an integrated body scanner; and a lightweight brain CT imager for early stroke diagnosis in ambulances. Micro-X has its core R&D, engineering and production capability in Adelaide, Australia with a fully in-sourced CNT tube manufacturing line and approximately 95% Australian locally manufactured content.

CONTACTS

Micro-X Limited	Investor Enquiries
Peter Rowland Managing Director Tel: +61 8 7099 3966 E:admin@micro-x.com	David Allen / John Granger Hawkesbury Partners Tel: +61 2 9103 9494 E:dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA

Page 2